Cells virus-infected

With respect to targeting viral gene products expressed in virus-infected cells, it should be considered that infectious mammalian viruses may express inhibitors of RNAi similar to plant viruses. 

Richardson JH, Child LA, Lever AM (1993) Packaging of human immunodeficiency virus type 1 RNA requires cis-acting sequences outside the 5 leader region, J Virol 67 3997 005 Roberts MR, Qin L, Zhang D, Smith DH, Tran AC, Dull TJ, Groopman JE, Capon DJ, Bym RA, Finer MH (1994) Targeting of human immunodeficiency virus-infected cells by CD8-I- T lymphocytes armed with universal T-cell receptors. Blood 84 2878-2889 Rooney CM, Smith CA, Ng CY, Loftin S, Li C, Krance RA, Brenner MK, Heslop HE (1995) Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lympho-proliferation. Lancet 345 9-13... 

Some research is now focused on the possibility of increasing the CTL responses that target virus-infected cells.Even though antibodies can play an important role in... 

Note that the protein kinase, which phosphorylates the IF-GDP complex is structurally similar to the protein kinase that is activated by double-stranded RNA, i.e. the genome of some viruses. This protein kinase phosphorylates the IF-GDP complex in an infected host cell, so that viral peptide synthesis is inhibited and the virus cannot multiply. Synthesis of this kinase is stimulated by the cytokine, interferon, which is released by virus-infected cells as an early-warning system to adjacent cells not yet infected (Chapter 17 see Figure 17.32). 

Interferons (IFN) are glycoproteins that, among other products, are released from virus-infected cells. In neighboring cells, interferon stimulates the production of "antiviral proteins." These inhibit the synthesis of viral proteins by (preferential) destruction of viral DNA or by suppressing its translation. Interferons are not directed against a specific virus, but have a broad spectrum of antiviral action that is, however, species-specific. Thus, interferon for use in humans must be obtained from cells of human origin, such as leukocytes (IFN-a), fibroblasts (IFN-P), or lymphocytes (IFN-y). Interferons are also used to treat certain malignancies and autoimmune disorders (e.g., IFN-a for chronic hepatitis C and hairy cell leukemia IFN-p for severe herpes virus infections and multiple sclerosis). 

Virus-infected cell, transplanted cell. tumor cell... 

Supported by CDS and other co-receptors, a T cell with a matching T cell receptor binds to the MHC peptide complex (5 cf p. 224). This binding activates protein kinases in the interior of the T cell, which trigger a chain of additional reactions (signal transduction see p. 388). Finally, destruction of the virus-infected cell by the cytotoxic T lymphocytes takes place. 

The growth of tissue (or, more precisely, the number of cells) is actually regulated by apoptosis. In addition, apoptosis allows the elimination of unwanted or superfluous cells—e.g., during embryonic development or in the immune system. The contraction of the uterus after birth is also based on apoptosis. Diseased cells are also eliminated by apoptosis—e.g., tumor cells, virus-infected cells, and cells with irreparably damaged DNA. An everyday example of this is the peeling of the skin after sunburn. 

The Fas/Fas ligand system has been recognized as a major pathway for the induction of apoptosis in cells and appears to play an important role in the normal development of T lymphocytes in the thymus by elimination of self-reactive lymphocytes and in the deletion of virus-infected cells and malignant cells (L7, N1,P1). 

NK-cells Kill virus-infected cells and some tiunor cells IxlO 7-500 d... 

TCell Mediated Cytoxidty against Virus-Infected Cells... 

Acyclovir Zovirax) is a guanine nucleoside analogue most effective against HSV-1 and HSV-2, but it has some activity against VCV, CMV, and EBV. Valacyclovir (Valtrex) is the L-valine ester prodrug of acyclovir. Acyclovir is converted to its active metabolite via three phosphorylation steps. First, viral thymidine kinase converts acyclovir to acyclovir monophosphate. Next, host cell enzymes convert the monophosphate to the diphosphate and then to the active compound, acyclovir triphosphate. Because viral thymidine kinase has a much greater affinity for acyclovir triphosphate than does mammalian thymidine kinase, acyclovir triphosphate accumulates only in virus-infected cells. 

Sudden infant death syndrome. Water-soluble smoke extract, in cell culture supernatants of mouse fibroblasts (L-929 cell line), produced an increase in TNF-a from respiratory syncytial virus-infected cells. It decreased TNF-a from cells incubated with toxic shock syndrome toxin. Incubation with cigarette smoke extract decreased the NO production from respiratory syncytial virus-infected cells and increased the NO production from cells incubated with toxic shock syndrome toxin. Monocytes from a minority of individuals demonstrated extreme TNF-a responses and/or very high or very low NO. The proportion of samples in which extreme responses with a very high TNF-a and very low NO were detected was increased in the presence of the three agents to 20% compared with 0% observed with toxic shock syndrome toxin. One to 4% was observed with cigarette smoke extract or respiratory syncytial virus L Symphatomimetic activity. Water extract of the dried leaf, administered intravenously to cats at doses of 0.05 and 10-20 mg/kg. 

Mechanism of Action Abiologic response modifier that inhibits viral replication in virus-infected cells, suppresses cell proliferation, increases phagocytic action of macrophages, and augments specific cytotoxicity of lymphocytes for target cells. Therapeutic Effect Inhibits viral growth in condylomata acuminata. 

Mectianism of Action An immunomodulator that binds to specific membrane receptors on the cell surface, inhibiting viral replication in virus-infected cells, suppressing cell proliferation, and producing reversible decreases in leukocyte and platelet counts. Therapeutic Effect Inhibits hepatitis C virus. 

Idoxuridine (9.7) and trifluridine (9.8) are antiviral agents that are phosphorylated to their active form in virus-infected cells, and thus show specificity for two reasons their higher affinity for the viral enzyme, and the higher phosphorylase levels in viral-infected than in normal cells. Both compounds have been used locally on lesions of HSV-1 and HSV-2 (the latter of which causes genital herpes, now reaching epidemic proportions) with fair success. They are rather toxic if administered parenterally, as are all moderately selective antimetabolities. 

Elimination of target cells (e.g., virus-infected cells) by cytotoxic T lymphocytes... 

Lyses virus-infected cell Secretes TNFp, IFNy, IL-2... 

---